Health Canada
Symbol of the Government of Canada
First Nations & Inuit Health

Drug Benefit List 2012

08:00 ANTI-INFECTIVE AGENTS

08:08.00 ANTHELMINTICS

MEBENDAZOLE

100mg Tablet
00556734 VERMOX JNO

PYRANTEL PAMOATE

50mg/mL Suspension
01944355 COMBANTRIN PFI
125mg Tablet
01944363 COMBANTRIN PFI

08:12.06 CEPHALOSPORINS

CEFACLOR

250mg Capsule
02230263 APO-CEFACLOR APX
00465186 CECLOR PHH
02231432 NU-CEFACLOR NXP
02237729 SCHEIN-CEFACLOR SCN
500mg Capsule
02230264 APO-CEFACLOR APX
00465194 CECLOR PHH
02231433 NU-CEFACLOR NXP
02237730 SCHEIN-CEFACLOR SCN
25mg/mL Suspension
00465208 CECLOR PHH
50mg/mL Suspension
00465216 CECLOR PHH
75mg/mL Suspension
02237502 APO-CEFACLOR APX
00832804 CECLOR BID PHH

CEFADROXIL

500mg Capsule
02240774 APO-CEFADROXIL APX
02311062 PRO-CEFADROXIL PDL
02235134 TEVA-CEFADROXIL TEV

CEFIXIME

20mg/mL Suspension
00868965 SUPRAX SAC
400mg Tablet
00868981 SUPRAX SAC

CEFPROZIL

25mg/mL Suspension
02293943 APO-CEFPROZIL APX
02163675 CEFZIL BMS
02329204 RAN-CEFPROZIL RBY
02303426 SANDOZ CEFPROZIL SDZ
50mg/mL Suspension
02293951 APO-CEFPROZIL APX
02163683 CEFZIL BMS
02293579 RAN-CEFPROZIL RBY
02303434 SANDOZ CEFPROZIL SDZ
250mg Tablet
02292998 APO-CEFPROZIL APX
02163659 CEFZIL BMS
02293528 RAN-CEFPROZIL RBY
02302179 SANDOZ CEFPROZIL SDZ

08:12.06 CEPHALOSPORINS

CEFPROZIL

500mg Tablet
02293005 APO-CEFPROZIL APX
02163667 CEFZIL BMS
02293536 RAN-CEFPROZIL RBY
02302187 SANDOZ CEFPROZIL SDZ

CEFUROXIME AXETIL

25mg/mL Suspension
02212307 CEFTIN GSK
250mg Tablet
02244393 APO-CEFUROXIME APX
02212277 CEFTIN GSK
02242656 RATIO-CEFUROXIME RPH
500mg Tablet
02244394 APO-CEFUROXIME APX
02212285 CEFTIN GSK
02311453 PRO-CEFUROXIME PDL
02242657 RATIO-CEFUROXIME RPH

CEPHALEXIN

250mg Capsule
00342084 NOVO-LEXIN TEV
500mg Capsule
00342114 NOVO-LEXIN TEV
25mg/mL Suspension
02177862 DOM-CEPHALEXIN DPC
00342106 NOVO-LEXIN TEV
50mg/mL Suspension
02177870 DOM-CEPHALEXIN DPC
00342092 NOVO-LEXIN TEV
250mg Tablet
00768723 APO-CEPHALEX APX
00828858 CEPHALEXIN PDL
02177846 DOM-CEPHALEXIN DPC
00583413 NOVO-LEXIN TEV
00865877 NU-CEPHALEX NXP
02177781 PMS-CEPHALEXIN PMS
500mg Tablet
00768715 APO-CEPHALEX APX
00828866 CEPHALEXIN PDL
02177854 DOM-CEPHALEXIN DPC
00583421 NOVO-LEXIN TEV
00865885 NU-CEPHALEX NXP
02177803 PMS-CEPHALEXIN PMS

08:12.12 MACROLIDES

AZITHROMYCIN

20mg/mL Suspension
02274388 PMS-AZITHROMYCIN PMS
02332388 SANDOZ-AZITHROMYCIN SDZ
02315157 TEVA-AZITHROMYCIN TEV
02223716 ZITHROMAX PFI
40mg/mL Suspension
02274396 PMS-AZITHROMYCIN PMS
02332396 SANDOZ-AZITHROMYCIN SDZ
02315165 TEVA-AZITHROMYCIN TEV
02223724 ZITHROMAX PFI
250mg Tablet
02247423 APO-AZITHROMYCIN APX
02330881 AZITHROMYCIN SAN
02255340 CO AZITHROMYCIN COB
02278359 MYLAN-AZITHROMYCIN MYL
02278588 PHL-AZITHROMYCIN PHH
02261634 PMS-AZITHROMYCIN PMS
02310600 PRO-AZITHROMYCIN PDL
02275287 RATIO-AZITHROMYCIN RPH
02275309 RIVA-AZITHROMYCIN RIV
02265826 SANDOZ-AZITHROMYCIN SDZ
02267845 TEVA-AZITHROMYCIN TEV
02212021 ZITHROMAX PFI
600mg Tablet
02256088 CO AZITHROMYCIN COB
02261642 PMS-AZITHROMYCIN PMS
02275317 RIVA-AZITHROMYCIN RIV
02231143 ZITHROMAX PFI

CLARITHROMYCIN

500mg Extended Release Tablet
02244756 BIAXIN XL ABB
250mg Film Coated Tablet
02274744 APO-CLARITHROMYCIN APX
01984853 BIAXIN ABB
02248856 MYLAN-CLARITHROMYCIN MYL
02247573 PMS-CLARITHROMYCIN PMS
02324482 PRO-CLARITHROMYCIN PDL
02361426 RAN-CLARITHROMYCIN RBY
02247818 RATIO-CLARITHROMYCIN RPH
02346524 RIVA-CLARITHROMYCIN RIV
02266539 SANDOZ-CLARITHROMYCIN SDZ
500mg Film Coated Tablet
02274752 APO-CLARITHROMYCIN APX
02126710 BIAXIN ABB
02351005 DOM-CLARITHROMYCIN SEV
02248857 MYLAN-CLARITHROMYCIN MYL
02247574 PMS-CLARITHROMYCIN PMS
02324490 PRO-CLARITHROMYCIN PDL
02361434 RAN-CLARITHROMYCIN RBY
02247819 RATIO-CLARITHROMYCIN RPH
02346532 RIVA-CLARITHROMYCIN RIV
02266547 SANDOZ-CLARITHROMYCIN SDZ
25mg/mL Suspension
02146908 BIAXIN ABB
50mg/mL Suspension
02244641 BIAXIN ABB

ERYTHROMYCIN

250mg Enteric Coated Capsule
00726672 APO-ERYTHRO APX
00607142 ERYC PFI
333mg Enteric Coated Capsule
01925938 APO-ERYTHRO APX
00873454 ERYC PFI
250mg Tablet
00682020 APO-ERYTHRO BASE APX

ERYTHROMYCIN ESTOLATE

50mg/mL Suspension
00262595 NOVO-RYTHRO ESTOLATE TEV

ERYTHROMYCIN ETHYLSUCCINATE

40mg/mL Suspension
00605859 NOVO-RYTHRO ETHYLSUCCINATE TEV
80mg/mL Suspension
00652318 NOVO-RYTHRO ETHYLSUCCINATE TEV
600mg Tablet
00637416 APO-ERYTHRO-S APX
00583782 EES-600 ABB
00704377 ERYTHRO-ES PDL

ERYTHROMYCIN STEARATE

250mg Tablet
00545678 APO-ERYTHRO-S APX
00563854 ERYTHROMYCIN PDL
02051850 NU-ERYTHROMYCIN S NXP
500mg Tablet
00688568 APO-ERYTHRO S APX
00704393 ERYTHRO PDL

08:12.16 PENICILLINS

AMOXICILLIN

250mg Capsule
02352710 AMOXICILLIN SAN
00628115 APO-AMOXI APX
02238171 MYLAN-AMOXICILLIN MYL
00406724 NOVAMOXIN TEV
00865567 NU-AMOXI NXP
02230243 PMS-AMOXICILLIN PMS
500mg Capsule
02352729 AMOXICILLIN SAN
00628123 APO-AMOXI APX
02238172 MYLAN-AMOXICILLIN MYL
00406716 NOVAMOXIN TEV
00865575 NU-AMOXI NXP
02230244 PMS-AMOXICILLIN PMS
00644315 PRO-AMOX PDL
125mg Chewable Tablet
02036347 NOVAMOXIN TEV
250mg Chewable Tablet
02352737 AMOXICILLIN SAN
02036355 NOVAMOXIN TEV
25mg/mL Oral Solution
01934171 NOVAMOXIN SUGAR TEV
REDUCED
50mg/mL Oral Solution
01934163 NOVAMOXIN SUGAR TEV
REDUCED
25mg/mL Suspension
02352745 AMOXICILLIN SAN
02352761 AMOXICILLIN SUGAR REDUCED SAN
00628131 APO-AMOXI APX
00452149 NOVAMOXIN TEV
00865540 NU-AMOXI NXP
02230245 PMS-AMOXICILLIN PMS
50mg/mL Suspension
02352753 AMOXICILLIN SAN
02352788 AMOXICILLIN SUGAR REDUCED SAN
00628158 APO-AMOXI APX
00452130 NOVAMOXIN TEV
00865559 NU-AMOXI NXP
02230246 PMS-AMOXICILLIN PMS
00644331 PRO-AMOX PDL

AMOXICILLIN, CLAVULANIC ACID

25mg & 6.25mg/mL Suspension
02243986 APO-AMOXI CLAV APX
01916882 CLAVULIN-F 125 GSK
40mg & 5.7mg/mL Suspension
02288559 APO-AMOXI CLAV APX
02238831 CLAVULIN 200 GSK
50mg & 12.5mg/mL Suspension
02243987 APO-AMOXI CLAV APX
01916874 CLAVULIN-F 250 GSK
80mg & 11.4mg/mL Suspension
02238830 CLAVULIN 400 GSK
250mg & 125mg Tablet
02243350 APO-AMOXI CLAV APX
500mg & 125mg Tablet
02326515 AMOXI-CLAV PDL
02243351 APO-AMOXI CLAV APX
01916858 CLAVULIN-F GSK
02243771 RATIO-ACLAVULANATE RPH
875mg & 125mg Tablet
02326523 AMOXI-CLAV PDL
02245623 APO-AMOXI CLAV APX
02238829 CLAVULIN GSK
02247021 RATIO-ACLAVULANATE RPH
02248138 TEVA-CLAVAMOXIN TEV

AMPICILLIN

250mg Capsule
00020877 TEVA-AMPICILLIN TEV
500mg Capsule
00020885 TEVA-AMPICILLIN TEV
25mg/mL Suspension
00717495 NU-AMPI NXP
50mg/mL Suspension
00603287 APO-AMPICILLIN APX
00717649 NU-AMPI NXP

CLOXACILLIN

250mg Capsule
02069660 CLOXACILLINE PRO
00717584 NU-CLOXI NXP
00337765 TEVA-CLOXIN TEV
500mg Capsule
02069679 CLOXACILLINE PRO
00717592 NU-CLOXI NXP
00337773 TEVA-CLOXIN TEV
25mg/mL Suspension
00717630 NU-CLOXI NXP
00337757 TEVA-CLOXIN TEV

PENICILLIN V POTASSIUM

25mg/mL Suspension
00642223 APO-PEN VK APX
60mg/mL Suspension
00642231 APO-PEN VK APX
00391603 NOVO-PEN VK TEV
300mg Tablet
00642215 APO-PEN VK APX
00021202 NOVO-PEN VK TEV
00717568 NU-PEN VK NXP
00468029 PENICILLINE V PDL

PIVMECILLINAM HCL

200mg Tablet
00657212 SELEXID LEO

08:12.18 QUINOLONES

CIPROFLOXACIN HCL

250mg Tablet
02229521 APO-CIPROFLOX APX
02155958 CIPRO BAY
02353318 CIPROFLOXACIN SAN
02247339 CO CIPROFLOXACIN COB
02317427 MINT-CIPROFLOXACIN MIN
02245647 MYLAN-CIPROFLOXACIN MYL
02251310 PHL-CIPROFLOXACIN PHH
02248437 PMS-CIPROFLOXACIN PMS
02317796 PRO-CIPROFLOXACIN PDL
02303728 RAN-CIPROFLOX RBY
02246825 RATIO-CIPROFLOXACIN RPH
02251221 RIVA-CIPROFLOXACIN RIV
02248756 SANDOZ-CIPROFLOXACIN SDZ
02266962 TARO-CIPROFLOXACIN TAR
02161737 TEVA-CIPROFLOXACIN TEV
500mg Tablet
02229522 APO-CIPROFLOX APX
02155966 CIPRO BAY
02353326 CIPROFLOXACIN SAN
02247340 CO CIPROFLOXACIN COB
02251280 DOM-CIPROFLOXACIN PMS
02317435 MINT-CIPROFLOXACIN MIN
02245648 MYLAN-CIPROFLOXACIN MYL
02251329 PHL-CIPROFLOXACIN PHH
02248438 PMS-CIPROFLOXACIN PMS
02317818 PRO-CIPROFLOXACIN PDL
02303736 RAN-CIPROFLOX RBY
02246826 RATIO-CIPROFLOXACIN RPH
02251248 RIVA-CIPROFLOXACIN RIV
02248757 SANDOZ-CIPROFLOXACIN SDZ
02266970 TARO-CIPROFLOXACIN TAR
02161745 TEVA-CIPROFLOXACIN TEV
750mg Tablet
02229523 APO-CIPROFLOX APX
02155974 CIPRO BAY
02353334 CIPROFLOXACIN SAN
02247341 CO CIPROFLOXACIN COB
02317443 MINT-CIPROFLOXACIN MIN
02245649 MYLAN-CIPROFLOXACIN MYL
02251337 PHL-CIPROFLOXACIN PHH
02248439 PMS-CIPROFLOXACIN PMS
02303744 RAN-CIPROFLOX RBY
02246827 RATIO-CIPROFLOXACIN RPH
02251256 RIVA-CIPROFLOXACIN RIV
02248758 SANDOZ-CIPROFLOXACIN SDZ
02161753 TEVA-CIPROFLOXACIN TEV

LEVOFLOXACIN

Limited use benefit (prior approval not required).

Coverage will be limited to a maximum of 14 days.

250mg Tablet
02284707 APO-LEVOFLOXACIN APX
02315424 CO-LEVOFLOXACIN COB
02236841 LEVAQUIN JNO
02313979 MYLAN-LEVOFLOXACIN MYL
02248262 NOVO-LEVOFLOXACIN TEV
02284677 PMS-LEVOFLOXACIN PMS
02298635 SANDOZ LEVOFLOXACIN SDZ
500mg Tablet
02284715 APO-LEVOFLOXACIN APX
02315432 CO-LEVOFLOXACIN COB
02236842 LEVAQUIN JNO
02313987 MYLAN-LEVOFLOXACIN MYL
02248263 NOVO-LEVOFLOXACIN TEV
02284685 PMS-LEVOFLOXACIN PMS
02298643 SANDOZ LEVOFLOXACIN SDZ
750mg Tablet
02325942 APO-LEVOFLOXACIN APX
02315440 CO-LEVOFLOXACIN COB
02246804 LEVAQUIN JNO
02285649 NOVO-LEVOFLOXACIN TEV
02305585 PMS-LEVOFLOXACIN PMS
02298651 SANDOZ LEVOFLOXACIN SDZ

NORFLOXACIN

400mg Tablet
02229524 APO-NORFLOX APX
02269627 CO NORFLOXACIN COB
02237682 NOVO-NORFLOXACIN TEV
02246596 PMS-NORFLOXACIN PMS
02241483 RIVA-NORFLOXACIN RIV
02301504 RIVA-NORFLOXACIN RIV

OFLOXACIN

200mg Tablet
02231529 OFLOXACIN AAP
300mg Tablet
02243475 NOVO-OFLOXACIN TEV
02231531 OFLOXACIN AAP
400mg Tablet
02231532 OFLOXACIN AAP

08:12.20 SULFONAMIDES

SULFAMETHOXAZOLE

500mg Tablet
00421480 APO-SULFAMETHOXAZOLE APX

SULFAMETHOXAZOLE, TRIMETHOPRIM

40mg & 8mg/mL Suspension
00726540 NOVO-TRIMEL TEV
100mg & 20mg Tablet
00445266 APO-SULFATRIM PED APX
400mg & 80mg Tablet
00445274 APO-SULFATRIM APX
00510637 NOVO-TRIMEL TEV
00865710 NU-COTRIMOX NXP
800mg & 160mg Tablet
00445282 APO-SULFATRIM DS APX
00510645 NOVO-TRIMEL DS TEV
00865729 NU-COTRIMOX DS NXP
00512524 PROTRIN DF PRO

SULFASALAZINE

500mg Enteric Coated Tablet
00598488 PMS-SULFASALAZINE PMS
02064472 SALAZOPYRIN PFI
500mg Tablet
00598461 PMS-SULFASALAZINE PMS
02064480 SALAZOPYRIN PFI

08:12.24 TETRACYCLINES

DOXYCYCLINE

100mg Capsule
00740713 APO-DOXY APX
00817120 DOXYCIN RIV
02351234 DOXYCYCLINE SAN
00725250 NOVO-DOXYLIN TEV
02044668 NU-DOXYCYCLINE NXP
100mg Tablet
00874256 APO-DOXY APX
00860751 DOXYCIN RIV
02351242 DOXYCYCLINE SAN
00887064 DOXYTAB PDL
02158574 NOVO-DOXYLIN TEV
02044676 NU-DOXYCYCLINE NXP

MINOCYCLINE HCL

Limited use benefit (prior approval required).

For:

  1. patients who cannot tolerate other tetracyclines.
  2. patients with severe widespread acne who have failed on tetracycline.
50mg Capsule
02084090 APO-MINOCYCLINE APX
02239667 DOM-MINOCYCLINE DPC
02153394 MINOCYCLINE PDL
02287226 MINOCYCLINE SAN
02230735 MYLAN-MINOCYCLINE MYL
02108143 NOVO-MINOCYCLINE TEV
02239238 PMS-MINOCYCLINE PMS
02294419 PMS-MINOCYCLINE PMS
02242080 RIVA-MINOCYCLINE RIV
02237313 SANDOZ-MINOCYCLINE SDZ
100mg Capsule
02084104 APO-MINOCYCLINE APX
02239668 DOM-MINOCYCLINE DPC
02173506 MINOCIN STI
02154366 MINOCYCLINE PDL
02239982 MINOCYCLINE IVX
02287234 MINOCYCLINE SAN
02230736 MYLAN-MINOCYCLINE MYL
02108151 NOVO-MINOCYCLINE TEV
02294427 PMS-MINOCYCLINE PMS
02239239 PMS-MONOCYCLINE PMS
02242081 RIVA-MINOCYCLINE RIV
02237314 SANDOZ-MINOCYCLINE SDZ

TETRACYCLINE HCL

250mg Capsule
00580929 APO-TETRA APX
00717606 NU-TETRA NXP
00156744 TETRACYCLINE PRO

08:12.28 MISCELLANEOUS ANTIBIOTICS

CLINDAMYCIN HCL

150mg Capsule
02245232 APO-CLINDAMYCIN APX
02248525 CLINDAMYCINE PDL
00030570 DALACIN C PFI
02258331 MYLAN-CLINDAMYCIN MYL
02242409 RIVA-CLINDAMYCIN RIV
02241709 TEVA-CLINDAMYCIN TEV
300mg Capsule
02245233 APO-CLINDAMYCIN APX
02248526 CLINDAMYCINE PDL
02182866 DALACIN C PFI
02258358 MYLAN-CLINDAMYCIN MYL
02242410 RIVA-CLINDAMYCIN RIV
02241710 TEVA-CLINDAMYCIN TEV

CLINDAMYCIN PALMITATE HCL

15mg/mL Solution
00225851 DALACIN C PFI

LINEZOLID

Limited use benefit (prior approval required).

Tablets:

For treatment of proven vancomycin-resistant enterococci (VRE) infections when other antibiotics are not available, and for the treatment of proven Methicillin-Resistant Staphylococcus aureus (MRSA) infections in patients who cannot tolerate or who had an idiosyncratic reaction with Vancomycin.

I.V. solution:

When linezolid cannot be administered orally in the above mentioned situations.

2mg/mL Injection
02243685 ZYVOXAM PFI
600mg Tablet
02243684 ZYVOXAM PFI

08:14.04 ALLYLAMINES

TERBINAFINE HCL

250mg Tablet
02239893 APO-TERBINAFINE APX
02254727 CO TERBINAFINE COB
02299275 DOM-TERBINAFINE DPC
02031116 LAMISIL NVR
02242503 MYLAN-TERBINAFINE MYL
02240346 NOVO-TERBINAFINE TEV
02248845 NU-TERBINAFINE NXP
02240807 PMS-TERBINAFINE PMS
02294273 PMS-TERBINAFINE PMS
02262924 RIVA-TERBINAFINE RIV
02262177 SANDOZ-TERBINAFINE SDZ
02242735 TERBINAFINE PDL
02353121 TERBINAFINE SAN

08:14.08 AZOLES

FLUCONAZOLE

150mg Capsule
02241895 APO-FLUCONAZOLE APX
02311690 CANESORAL BAY
02323419 CO FLUCONAZOLE COB
02141442 DIFLUCAN PFI
02243645 NOVO-FLUCONAZOLE TEV
02246620 PMS-FLUCONAZOLE PMS
02282348 PMS-FLUCONAZOLE PMS
02310694 PRO-FLUCONAZOLE PDL
02255510 RIVA-FLUCONAZOLE RIV
10mg/mL Suspension
02024152 DIFLUCAN PFI
50mg Tablet
02237370 APO-FLUCONAZOLE APX
02281260 CO FLUCONAZOLE COB
00891800 DIFLUCAN PFI
02245292 MYLAN-FLUCONAZOLE MYL
02236978 NOVO-FLUCONAZOLE TEV
02245643 PMS-FLUCONAZOLE PMS
02249294 TARO-FLUCONAZOLE TAR
100mg Tablet
02237371 APO-FLUCONAZOLE APX
02281279 CO FLUCONAZOLE COB
02245293 MYLAN-FLUCONAZOLE MYL
02236979 NOVO-FLUCONAZOLE TEV
02245644 PMS-FLUCONAZOLE PMS
02310686 PRO-FLUCONAZOLE PDL
02271516 RIVA-FLUCONAZOLE RIV
02249308 TAR0-FLUCONAZOLE TAR

ITRACONAZOLE

100mg Capsule
02047454 SPORANOX JNO
10mg/mL Solution
02231347 SPORANOX JNO

KETOCONAZOLE

200mg Tablet
02237235 APO-KETOCONAZOLE APX
02231061 NOVO-KETOCONAZOLE TEV
02122197 NU-KETOCON NXP

VORICONAZOLE

Limited use benefit (prior approval required).

For the treatment of:

  1. patients with invasive aspergillosis.
  2. culture proven invasive candidiasis with documented resistance to fluconazole.
50mg Tablet
02256460 VFEND PFI
200mg Tablet
02256479 VFEND PFI

08:14.28 POLYENES

NYSTATIN

100,000U/mL Suspension
02125145 DOM-NYSTATIN DPC
00792667 PMS-NYSTATIN PMS
02194201 RATIO-NYSTATIN RPH
500,000U Tablet
02194198 RATIO-NYSTATIN RPH

08:16.04 ANTITUBERCULOSIS AGENTS

ETHAMBUTOL HCL

100mg Tablet
00247960 ETIBI VAE
400mg Tablet
00247979 ETIBI VAE

ISONIAZID

10mg/mL Syrup
00265500 ISOTAMINE VAE
00577812 PMS-ISONIAZID PMS
300mg Tablet
00272655 ISOTAMINE VAE
00577804 PMS-ISONIAZID PMS

PYRAZINAMIDE

500mg Tablet
00618810 PMS-PYRAZINAMIDE PMS
00283991 TEBRAZID VAE

RIFABUTIN

150mg Capsule
02063786 MYCOBUTIN PFI

RIFAMPIN

150mg Capsule
02091887 RIFADIN SAC
00393444 ROFACT VAE
300mg Capsule
02092808 RIFADIN SAC
00343617 ROFACT VAE

08:18.04 ADAMANTANES

AMANTADINE HCL

100mg Capsule
02130963 DOM-AMANTADINE DPC
02139200 MYLAN-AMANTADINE MYL
01990403 PMS-AMANTADINE PMS
10mg/mL Syrup
02022826 PMS-AMANTADINE PMS

08:18.08 ANTIRETROVIRALS

ABACAVIR

20mg/mL Oral Liquid
02240358 ZIAGEN GSK
300mg Tablet
02240357 ZIAGEN GSK

ABACAVIR, LAMIVUDINE

600mg & 300mg Tablet
02269341 KIVEXA GSK

ABACAVIR, LAMIVUDINE, ZIDOVUDINE

300mg & 150mg & 300mg Tablet
02244757 TRIZIVIR GSK

ATAZANAVIR SULFATE

150mg Capsule
02248610 REYATAZ BMS
200mg Capsule
02248611 REYATAZ BMS
300mg Capsule
02294176 REYATAZ BMS

DARUNAVIR

75mg Tablet
02338432 PREZISTA JNO

DARUNAVIR

400mg Tablet
02324016 PREZISTA JNO
600mg Tablet
02324024 PREZISTA JNO

DIDANOSINE

125mg Capsule
02244596 VIDEX EC BMS
200mg Capsule
02244597 VIDEX EC BMS
250mg Capsule
02244598 VIDEX EC BMS
400mg Capsule
02244599 VIDEX EC BMS

EFAVIRENZ

50mg Capsule
02239886 SUSTIVA BMS
200mg Capsule
02239888 SUSTIVA BMS
600mg Tablet
02246045 SUSTIVA BMS

EFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE

Limited use benefit (prior approval required).

For the treatment of HIV-1 infection adults where the virus is susceptible to each of tenofovir, emtricitabine and efavirenz, and:

  1. Atripla is used to replace existing therapy with its component drugs, or
  2. the patient is treatment na�ve, or
  3. the patient has established viral suppression but requires antiretroviral therapy modification due to intolerance or adverse effects.

Note: Criteria will be confirmed against medication history.

600mg & 200mg & 300mg Tablet
02300699 ATRIPLA BMS

EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE

Limited use benefit (prior approval required).

For the treatment of patients with HIV infection where the virus is susceptible to both emtricitabine and tenofovir AND where the triple-entity antiretroviral agent (tenofovir/ emtricitabine/efavirenz) is not indicated due to one of the following:

  1. efavirenz resistance
  2. adverse effects secondary to efavirenz
200mg/300mg Tablet
02274906 TRUVADA GIL

ETRAVIRINE

Limited use benefit (prior approval required).

For use in combination with other antiretroviral agents for treatment-experienced patients with HIV-1 infection who:

  1. have failed prior antiretroviral therapy; and
  2. have HIV-1 strains resistant to multiple antiretroviral agents, including NNRTIs
100mg Tablet
02306778 INTELENCE JNO

FOSAMPRENAVIR CALCIUM

50mg/mL Oral Suspension
02261553 TELZIR GSK
700mg Tablet
02261545 TELZIR GSK

INDINAVIR SULFATE

200mg Capsule
02229161 CRIXIVAN FRS
400mg Capsule
02229196 CRIXIVAN FRS

LAMIVUDINE

10mg/mL Solution
02192691 3TC GSK
100mg Tablet
02239193 HEPTOVIR GSK
150mg Tablet
02192683 3TC GSK
300mg Tablet
02247825 3TC GSK

LAMIVUDINE, ZIDOVUDINE

150mg & 300mg Tablet
02239213 COMBIVIR GSK

LOPINAVIR, RITONAVIR

80mg & 20mg/mL Oral Solution
02243644 KALETRA ABB
100mg & 25mg Tablet
02312301 KALETRA ABB
200mg & 50mg Tablet
02285533 KALETRA ABB

MARAVIROC

Limited use benefit (prior approval required).

For the treatment of HIV-1 infection, given in combination with other antiretroviral agents, in patients who have:

  1. CR5 tropic viruses; and
  2. documented resistance to at least one agent from each of the three major classes of antiretroviral agents (nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, and protease inhibitors)
150mg Tablet
02299844 CELSENTRI GSK
300mg Tablet
02299852 CELSENTRI GSK

NELFINAVIR MESYLATE

50mg/g Powder for Suspension
02238618 VIRACEPT PFI

NELFINAVIR MESYLATE

250mg Tablet
02238617 VIRACEPT PFI
625mg Tablet
02248761 VIRACEPT PFI

NEVIRAPINE

200mg Tablet
02318601 AURO-NEVIRAPINE AUR
02352893 TEVA-NEVIRAPINE TEV
02238748 VIRAMUNE BOE

RALTEGRAVIR

Limited use benefit (prior approval required).

For the treatment of HIV infection in patients who are antiretroviral experienced and have virologic failure due to resistance to at least one agent from each of the three major classes of antiretroviral agents, nucleoside/tide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors.

400mg Tablet
02301881 ISENTRESS FRS

RITONAVIR

100mg Capsule
02241480 NORVIR SEC ABB
80mg/mL Liquid
02229145 NORVIR ABB
100mg Tablet
02357593 NORVIR ABB

SAQUINAVIR MESYLATE

200mg Capsule
02216965 INVIRASE HLR
500mg Tablet
02279320 INVIRASE HLR

STAVUDINE

15mg Capsule
02216086 ZERIT BMS
20mg Capsule
02216094 ZERIT BMS
30mg Capsule
02216108 ZERIT BMS
40mg Capsule
02216116 ZERIT BMS

TENOFOVIR DISOPROXIL FUMARATE

Limited use benefit (prior approval required).

For the management of HIV disease in patients who have failed or have experienced adverse events to an alternative nucleoside reverse transcriptase inhibitor.

245mg Tablet
02247128 VIREAD GIL

TIPRANAVIR

Limited use benefit (prior approval required).

For the management of HIV disease in patients

  1. who have failed all currently listed protease inhibitors
  2. intolerant to all currently listed protease inhibitors
250mg Capsule
02273322 APTIVUS BOE

ZIDOVUDINE

100mg Capsule
01946323 APO-ZIDOVUDINE APX
01902660 RETROVIR GSK
10mg/mL Syrup
01902652 RETROVIR GSK

08:18.20 INTERFERONS

PEGINTERFERON ALFA-2A

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
180mcg/0.5mL Injection
02248077 PEGASYS HLR
180mcg/1mL Injection
02248078 PEGASYS HLR

PEGINTERFERON ALFA-2A, RIBAVIRIN

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
180mcg/0.5mL & 200mg Injection & Tablet
02253429 PEGASYS RBV HLR
180mcg/1mL & 200mg Injection & Tablet
02253410 PEGASYS RBV HLR

PEGINTERFERON ALFA-2B

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered.
74mcg/Vial Injection
02242966 UNITRON PEG SCH
118.4mcg/Vial Injection
02242967 UNITRON PEG SCH
177.6mcg/Vial Injection
02242968 UNITRON PEG SCH
222mcg/Vial Injection
02242969 UNITRON PEG SCH

PEGINTERFERON ALFA-2B, RIBAVIRIN

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
50mcg/0.5mL & 200mg Injection & Capsule
02246026 PEGETRON SCH
02254573 PEGETRON REDIPEN SCH
80mcg/0.5mL & 200mg Injection & Capsule
02246027 PEGETRON SCH
02254581 PEGETRON REDIPEN SCH
100mcg/0.5mL & 200mg Injection & Capsule
02246028 PEGETRON SCH
02254603 PEGETRON REDIPEN SCH
120mcg/0.5mL & 200mg Injection & Capsule
02246029 PEGETRON SCH
02254638 PEGETRON REDIPEN SCH
150mcg/0.5mL & 200mg Injection & Capsule
02246030 PEGETRON SCH
02254646 PEGETRON REDIPEN SCH

08:18.32 NUCLEOSIDES AND NUCLEOTIDES

ACYCLOVIR

40mg/mL Suspension
00886157 ZOVIRAX GSK
200mg Tablet
02286556 ACYCLOVIR SAN
02207621 APO-ACYCLOVIR APX
02242784 MYLAN-ACYCLOVIR MYL
02197405 NU-ACYCLOVIR NXP
02078627 RATIO-ACYCLOVIR RPH
02285959 TEVA-ACYCLOVIR TEV
00634506 ZOVIRAX GSK
400mg Tablet
02286564 ACYCLOVIR SAN
02207648 APO-ACYCLOVIR APX
02242463 MYLAN-ACYCLOVIR MYL
02197413 NU-ACYCLOVIR NXP
02078635 RATIO-ACYCLOVIR RPH
02285967 TEVA-ACYCLOVIR TEV
01911627 ZOVIRAX GSK
800mg Tablet
02286572 ACYCLOVIR SAN
02207656 APO-ACYCLOVIR APX
02242464 MYLAN-ACYCLOVIR MYL
02197421 NU-ACYCLOVIR NXP
02078651 RATIO-ACYCLOVIR RPH
02285975 TEVA-ACYCLOVIR TEV
01911635 ZOVIRAX GSK

ADEFOVIR DIPIVOXIL

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis B infection when used in combination with lamivudine in patients who have developed failure to lamivudine, as defined by an increase in HBV DNA of = 1 log10 IU/mL above the nadir, measured on two separate occasions within an interval of at least one month, after the first three months of lamivudine therapy, and when failure to lamivudine is not due to poor adherence to

10mg Tablet
02247823 HEPSERA GIL

ENTECAVIR

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis B infection in patients with cirrhosis documented on radiologic or histologic grounds and a HBV DNA concentration above 2000IU/mL.

0.5mg Tablet
02282224 BARACLUDE BMS

FAMCICLOVIR

125mg Tablet
02292025 APO-FAMCICLOVIR APX
02305682 CO FAMCICLOVIR COB
02324865 FAMCICLOVIR PDL
02229110 FAMVIR NVR
02278081 PMS-FAMCICLOVIR PMS
02278634 SANDOZ-FAMCICLOVIR SDZ
250mg Tablet
02292041 APO-FAMCICLOVIR APX
02305690 CO FAMCICLOVIR COB
02229129 FAMVIR NVR
02278103 PMS-FAMCICLOVIR PMS
02278642 SANDOZ-FAMCICLOVIR SDZ
500mg Tablet
02292068 APO-FAMCICLOVIR APX
02305704 CO FAMCICLOVIR COB
02177102 FAMVIR NVR
02278111 PMS-FAMCICLOVIR PMS
02278650 SANDOZ-FAMCICLOVIR SDZ

GANCICLOVIR SODIUM

500mg Injection
02162695 CYTOVENE HLR

VALACYCLOVIR HCL

500mg Tablet
02295822 APO-VALACYCLOVIR APX
02331748 CO VALACYCLOVIR COB
02307936 DOM-VALACYCLOVIR DPC
02351579 MYLAN-VALACYCLOVIR MYL
02298457 PMS-VALACYCLOVIR PMS
02315173 PRO-VALACYCLOVIR PDL
02316447 RIVA-VALACYCLOVIR RIV
02219492 VALTREX GSK

VALGANCICLOVIR HCL

450mg Tablet
02245777 VALCYTE HLR

08:30.04 AMEBICIDES

DIIODOHYDROXYQUIN

210mg Tablet
01997769 DIODOQUIN GLE
650mg Tablet
01997750 DIODOQUIN GLE

PAROMOMYCIN SULFATE

250mg Capsule
02078759 HUMATIN ERF

08:30.08 ANTIMALARIALS

CHLOROQUINE PHOSPHATE

250mg Tablet
000021261 TEVA-CHLOROQUINE TEV

HYDROXYCHLOROQUINE SULFATE

200mg Tablet
02246691 APO-HYDROXYQUINE APX
02252600 MYLAN-HYDROXYCHLOROQUINE MYL
02017709 PLAQUENIL SAC
02311011 PRO-HYDROXYQUINE PDL

PRIMAQUINE PHOSPHATE

26.3mg Tablet
02017776 PRIMAQUINE SAC

PYRIMETHAMINE

25mg Tablet
4774 DARAPRIM GSK

08:30.92 MISCELLANEOUS ANTIPROTOZOALS

ATOVAQUONE

150mg/mL Suspension
02217422 MEPRON GSK

METRONIDAZOLE

500mg Capsule
02248562 METRONIDAZOLE AAP
250mg Tablet
00420409 METRONIDAZOLE PDL
00545066 METRONIDAZOLE AAP

08:36.00 URINARY ANTI-INFECTIVES

NITROFURANTOIN

50mg Capsule
02231015 NOVO-FURANTOIN TEV
100mg Capsule
02063662 MACROBID PGP
02231016 NOVO-FURANTOIN TEV
50mg Tablet
00319511 NITROFURANTOIN AAP
100mg Tablet
00312738 NITROFURANTOIN AAP

TRIMETHOPRIM

100mg Tablet
02243116 TRIMETHOPRIM AAP
200mg Tablet
02243117 TRIMETHOPRIM AAP